메뉴 건너뛰기




Volumn 26, Issue 3, 1996, Pages 321-332

Identification and antimicrobial activity of urinary metabolites of a rifamycin derivative in dog

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; RIFALAZIL; RIFAMYCIN DERIVATIVE;

EID: 0029872462     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046711     Document Type: Article
Times cited : (11)

References (14)
  • 1
    • 0027971263 scopus 로고
    • Activity of KRM-1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection
    • BERMUDEZ, L. E., KOLONOSKI, P., YOUNG, L. S., and INDERLIED, C. B., 1994, Activity of KRM-1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection. Antimicrobial Agents and Chemotherapy, 38, 1844-1848.
    • (1994) Antimicrobial Agents and Chemotherapy , vol.38 , pp. 1844-1848
    • Bermudez, L.E.1    Kolonoski, P.2    Young, L.S.3    Inderlied, C.B.4
  • 2
    • 0027537219 scopus 로고
    • Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits
    • EMORI, M., SAITO, H., SATO, K., TOMIOKA, H., SETOGAWA, T., and HIDAKA, T., 1993, Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental Mycobacterium avium infection induced in rabbits. Antimicrobial Agents and Chemotherapy, 37, 722-728.
    • (1993) Antimicrobial Agents and Chemotherapy , vol.37 , pp. 722-728
    • Emori, M.1    Saito, H.2    Sato, K.3    Tomioka, H.4    Setogawa, T.5    Hidaka, T.6
  • 3
    • 0028352117 scopus 로고
    • In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives
    • FUJII, K., TSUJI, A., MIYAZAKI, S., YAMAGUCHI, K., and GOTO, S., 1994, In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives. Antimicrobial Agents and Chemotherapy, 38, 1118-1122.
    • (1994) Antimicrobial Agents and Chemotherapy , vol.38 , pp. 1118-1122
    • Fujii, K.1    Tsuji, A.2    Miyazaki, S.3    Yamaguchi, K.4    Goto, S.5
  • 4
    • 0023630956 scopus 로고
    • Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimicrobial agents by various methods
    • INDERLIED, C. B., YOUNG, L. S., and YAMAHA, J. K., 1987, Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimicrobial agents by various methods. Antimicrobial Agents and Chemotherapy, 31, 1697-1702.
    • (1987) Antimicrobial Agents and Chemotherapy , vol.31 , pp. 1697-1702
    • Inderlied, C.B.1    Young, L.S.2    Yamaha, J.K.3
  • 5
    • 0028114141 scopus 로고
    • Activity of the benzoxazinorifamycin KRM-1648 and ethambutol against Mycobacterium avium complex in vitro and macrophages
    • INDERLIED, C. B., BARBARA-BURNHAM, L., WU, M., YOUNG, L. S., and BERMUDEZ, L. E., 1994, Activity of the benzoxazinorifamycin KRM-1648 and ethambutol against Mycobacterium avium complex in vitro and macrophages. Antimicrobial Agents and Chemotherapy, 38, 1838-1843.
    • (1994) Antimicrobial Agents and Chemotherapy , vol.38 , pp. 1838-1843
    • Inderlied, C.B.1    Barbara-Burnham, L.2    Wu, M.3    Young, L.S.4    Bermudez, L.E.5
  • 6
    • 0028093427 scopus 로고
    • Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model
    • KLEMENS, S. P., GROSSI, M. A., and CYNAMON, M. H., 1994, Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy, 38, 2245-2248.
    • (1994) Antimicrobial Agents and Chemotherapy , vol.38 , pp. 2245-2248
    • Klemens, S.P.1    Grossi, M.A.2    Cynamon, M.H.3
  • 7
    • 0025977668 scopus 로고
    • In vitro activities of new rifamycin derivatives against mycobacteria
    • KUZE, F., YAMAMOTO, T., AMITANI, R., and SUZUKI, K., 1991, In vitro activities of new rifamycin derivatives against mycobacteria. Kekkaku, 66, 7-12.
    • (1991) Kekkaku , vol.66 , pp. 7-12
    • Kuze, F.1    Yamamoto, T.2    Amitani, R.3    Suzuki, K.4
  • 8
    • 0028835430 scopus 로고
    • In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli
    • LUNA-HERRERA, J., REDDY, M. V., and GANGADHARAM, P. R. J., 1995, In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli. Antimicrobial Agents and Chemotherapy, 39, 440-444.
    • (1995) Antimicrobial Agents and Chemotherapy , vol.39 , pp. 440-444
    • Luna-Herrera, J.1    Reddy, M.V.2    Gangadharam, P.R.J.3
  • 10
    • 4243319784 scopus 로고
    • Antimicrobial susceptibility tests
    • edited by A. J. Ristuccia and B. A. Cunha (New York: Raven)
    • TILTON, R. C., 1984, Antimicrobial susceptibility tests. In Antimicrobial Therapy, edited by A. J. Ristuccia and B. A. Cunha (New York: Raven), pp. 137-145.
    • (1984) Antimicrobial Therapy , pp. 137-145
    • Tilton, R.C.1
  • 11
    • 0026515252 scopus 로고
    • Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice
    • TOMIOKA, H., SAITO, H., SATO, K., YAMANE, T., YAMASHITA, K., HOSOE, K., FUJII, K., and HIDAKA, T., 1992. Chemotherapeutic efficacy of a newly synthesized benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex infection induced in mice. Antimicrobial Agents and Chemotherapy, 36, 387-393.
    • (1992) Antimicrobial Agents and Chemotherapy , vol.36 , pp. 387-393
    • Tomioka, H.1    Saito, H.2    Sato, K.3    Yamane, T.4    Yamashita, K.5    Hosoe, K.6    Fujii, K.7    Hidaka, T.8
  • 12
    • 0027446212 scopus 로고
    • In vitro antimicrobial activity benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex determined by the radiometric method
    • TOMIOKA, H., SAITO, H., FUJII, K., SATO, K., and HIDAKA, T., 1993, In vitro antimicrobial activity benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex determined by the radiometric method. Antimicrobial Agents and Chemotherapy, 37, 67-70.
    • (1993) Antimicrobial Agents and Chemotherapy , vol.37 , pp. 67-70
    • Tomioka, H.1    Saito, H.2    Fujii, K.3    Sato, K.4    Hidaka, T.5
  • 13
    • 0025634037 scopus 로고
    • In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex
    • YAMAMOTO, T., AMITANI, R., KUZE, F., and SUZUKI, K., 1990, In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex. Kekkaku, 65, 805-810.
    • (1990) Kekkaku , vol.65 , pp. 805-810
    • Yamamoto, T.1    Amitani, R.2    Kuze, F.3    Suzuki, K.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.